What is hormone therapy for cancer and who needs it

May 19, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Hormone Therapy for Cancer: An Educational Overview

What Is Hormone Therapy?

Hormone therapy (also called endocrine therapy or hormonal treatment) is a type of cancer treatment that works by blocking hormones that fuel certain cancers' growth. Some cancers depend on specific hormones—like estrogen or testosterone—to survive and multiply. Hormone therapy either:

  • Blocks hormone production in the body
  • Prevents hormones from attaching to cancer cells (like putting a lock on the door so the hormone can't enter)
  • Destroys hormone-producing cells

Think of it like cutting off a cancer's fuel supply rather than directly attacking the cancer cells themselves.

Who Needs Hormone Therapy?

Hormone therapy is used for cancers that are "hormone receptor-positive," meaning the cancer cells have receptors (attachment points) for specific hormones. The most common are:

Breast Cancer

  • ER-positive (estrogen receptor-positive) and/or PR-positive (progesterone receptor-positive) breast cancers respond to hormone therapy
  • According to NCCN Guidelines for Breast Cancer, hormone therapy is a standard treatment option for hormone receptor-positive disease, often used for 5-10 years
  • May be used alone or combined with other treatments like chemotherapy or targeted therapy

Prostate Cancer

  • Advanced prostate cancers often depend on testosterone
  • NCCN Guidelines for Prostate Cancer recommend hormone therapy (androgen deprivation therapy) for advanced disease
  • Works by lowering testosterone levels or blocking its effects

Endometrial Cancer

  • Some endometrial cancers are hormone receptor-positive
  • Hormone therapy may be considered for advanced or recurrent disease

Other Hormone-Sensitive Cancers

  • Ovarian cancer (in some cases)
  • Thyroid cancer (specific types)

How Doctors Decide If You Need It

Your medical team will:

  1. Test your cancer for hormone receptors (this is part of pathology testing)
  2. Review your cancer stage and other risk factors
  3. Consider your overall health and treatment goals
  4. Discuss benefits and side effects with you

Common Hormone Therapy Medications

For breast cancer:

  • Tamoxifen (blocks estrogen in breast tissue)
  • Aromatase inhibitors like letrozole, anastrozole, exemestane (reduce estrogen production)
  • Fulvestrant (destroys estrogen receptors)

For prostate cancer:

  • GnRH agonists (reduce testosterone)
  • Anti-androgens (block testosterone effects)

Important Questions to Ask Your Doctor

If hormone therapy has been recommended for you:

  1. Is my cancer hormone receptor-positive? What are my specific receptor results?
  2. Why is hormone therapy recommended for my situation specifically?
  3. How long will I need hormone therapy?
  4. What side effects should I expect, and how can we manage them?
  5. Will I take hormone therapy alone or combined with other treatments?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2

It is h3k27 altered dmg h3k27m negative, egfr a289v myc tp53 mgmt methylated

Your tumor has specific genetic changes H3K27, EGFR, MYC, TP53, MGMT that your doctors will use to guide treatment decisions—these findings help deter